首页> 外文期刊>Asia-Pacific Biotech News >Covance Receives Frost ft Sullivan Asia Pacific CRO Growth Excellence Leadership Award Three Years Running
【24h】

Covance Receives Frost ft Sullivan Asia Pacific CRO Growth Excellence Leadership Award Three Years Running

机译:Covance连续三年获得Frost ft Sullivan亚太地区CRO增长卓越领导奖

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Burlington, NC - Laboratory Corporation of America~R Holdings (LabCorp~R) announced today (Oct 13) that Covance Drug Development ("Covance") has been awarded the 2016 Frost Et Sullivan Asia Pacific CRO Growth Excellence Leadership Award. Covance has received this significant recognition for three consecutive years for its continuing efforts to expand the scope of drug development services it provides in the growing Asia Pacific region.
机译:美国北卡罗来纳州伯灵顿市-美国实验室公司〜R Holdings(LabCorp〜R)今天(10月13日)宣布,Covance药物开发公司(“ Covance”)已获得2016年Frost Et Sullivan亚太地区CRO增长卓越领导奖。由于Covance不断努力扩大其在不断发展的亚太地区所提供的药物开发服务范围,因此连续三年获得此殊荣。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号